Novo Nordisk (NVO)
(Delayed Data from NYSE)
$142.40 USD
+1.40 (0.99%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $142.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Brokerage Reports
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 61 - 80 ( 194 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department